---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-25-013048"
form_type: "8-K"
ticker: "PAVM"
cik: "0001624326"
company_name: "PAVmed Inc."
filed_at: "2025-09-11T23:59:59+00:00"
generated_at: "2026-05-17T06:53:03.581198+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# PAVmed subsidiary Lucid Diagnostics closes $28.75M stock offering at $1.00/share

## Summary
- Lucid Diagnostics sold 28.75M shares at $1.00 each via underwritten offering.
- Underwriters' option for 3.75M shares exercised in full at closing.
- Net proceeds expected to be approximately $26.9 million after expenses.
- Funds to be used for working capital and general corporate purposes.

## SEC filing metadata
- accession: 0001493152-25-013048
- form_type: 8-K
- ticker: PAVM
- cik: 0001624326
- company_name: PAVmed Inc.
- filed_at: 2025-09-11T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1624326/000149315225013048/0001493152-25-013048-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1624326/000149315225013048/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-25-013048
- JSON: https://secwatch.observer/filing/0001493152-25-013048.json
- Plain text: https://secwatch.observer/filing/0001493152-25-013048.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.